Login to LORIS
A WebGL-compatible browser is required for full functionality (Mozilla Firefox, Google Chrome)
Welcome to the PREVENT-AD registered resource
The PREVENT-AD (Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease) cohort is composed of cognitively healthy participants over 55 years old, at risk of developing Alzheimer Disease (AD) as their parents and/or siblings were/are affected by the disease. These ‘at-risk’ participants have been followed for a naturalistic study of the presymptomatic phase of AD since 2011 using multimodal measurements of various disease indicators. Two clinical trials intended to test pharmaco-preventive agents have also been conducted.
The PREVENT-AD research group is now releasing additional data openly through registered access with the intention to contribute to the community’s growing understanding of AD pathogenesis.